Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | 383 314 | déclaré | 29 déc. 2025 | tx 95+1 197 709−587 633 |
| THOMPSON DESIGNS INC | 360 000 | déclaré | 12 juin 2019 | tx 3+7 860 000 |
| NEXMED INC | 267 948 | déclaré | 06 oct. 2009 | tx 12+239 748 |
| ZEVRA THERAPEUTICS, INC. | 10 835 | déclaré | 09 mars 2023 | tx 19+173 372 |
| BIOJECT MEDICAL TECHNOLOGIES INC | 0 | déclaré | 30 avr. 2014 | tx 17+445 334−156 400 |
| Valera Pharmaceuticals Inc | 0 | déclaré | 17 avr. 2007 | tx 11+146 500−609 000 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 29 déc. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 334 | — | |
| 29 déc. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 334 | 0.00 USD | deriv |
| 08 déc. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 413 | — | |
| 08 déc. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 413 | 0.00 USD | deriv |
| 21 nov. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 947 | — | |
| 20 nov. 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 18 115 | 0.00 USD | deriv |
| 20 nov. 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 5 468 | 0.00 USD | deriv |
| 21 nov. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 947 | 0.00 USD | deriv |
| 27 août 2025 | SALE | CATALYST PHARMACEUTICALS, INC. | 26 000 | 20.20 USD | |
| 27 août 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 50 000 | 2.24 USD | |
| 27 août 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 50 000 | 0.00 USD | deriv |
| 14 févr. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 4 000 | — | |
| 14 févr. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 4 000 | 0.00 USD | deriv |
| 27 déc. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 333 | — | |
| 27 déc. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 333 | 0.00 USD | deriv |
| 09 déc. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 413 | — | |
| 09 déc. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 413 | 0.00 USD | deriv |
| 21 nov. 2024 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 23 248 | 0.00 USD | deriv |
| 21 nov. 2024 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 2 841 | 0.00 USD | deriv |
| 21 août 2024 | SALE | CATALYST PHARMACEUTICALS, INC. | 15 000 | 20.10 USD | |
| 21 août 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 15 000 | 4.01 USD | |
| 22 août 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 15 000 | 0.00 USD | deriv |
| 08 avr. 2024 | SALE | CATALYST PHARMACEUTICALS, INC. | 25 000 | 15.68 USD | |
| 08 avr. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 25 000 | 4.01 USD | |
| 08 avr. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 25 000 | 0.00 USD | deriv |
8 achats déclarés après au moins 12 mois de silence — dernière occurrence le 30 nov. 2021.